Company: Valeant's Zelapar for Parkinson's gets conditional FDA approval

10/5/2005 |

The FDA granted Valeant Pharmaceuticals International conditional approval for its drug Zelapar, used for treating Parkinson's disease, the company said. The agency told the company it would need clarification of information it had previously supplied about the drug, which once before had received conditional approval when it was owned by Amarin. Valeant acquired the Amarin's U.S. unit last year.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL